You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
First Clinical Experience with α-Emitting Radium-223 in the Treatment of Skeletal Metastases
|
|---|---|
| Published in |
Clinical Cancer Research, June 2005
|
| DOI | 10.1158/1078-0432.ccr-04-2244 |
| Pubmed ID | |
| Authors |
Sten Nilsson, Roy H. Larsen, Sophie D. Fosså, Lise Balteskard, Kari W. Borch, Jan-Erik Westlin, Gro Salberg, Øyvind S. Bruland |
| Abstract |
The main goals were to study the safety and tolerability of the alpha-emitter radium-223 (223Ra) in breast and prostate cancer patients with skeletal metastases. In addition, pain palliation was evaluated. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 4 | 80% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 179 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Italy | 1 | <1% |
| Brazil | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 174 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 31 | 17% |
| Other | 22 | 12% |
| Student > Bachelor | 22 | 12% |
| Student > Master | 19 | 11% |
| Researcher | 18 | 10% |
| Other | 34 | 19% |
| Unknown | 33 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 61 | 34% |
| Chemistry | 17 | 9% |
| Physics and Astronomy | 15 | 8% |
| Biochemistry, Genetics and Molecular Biology | 12 | 7% |
| Engineering | 9 | 5% |
| Other | 26 | 15% |
| Unknown | 39 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 June 2022.
All research outputs
#1,936,297
of 22,753,345 outputs
Outputs from Clinical Cancer Research
#1,555
of 12,570 outputs
Outputs of similar age
#3,010
of 57,215 outputs
Outputs of similar age from Clinical Cancer Research
#7
of 160 outputs
Altmetric has tracked 22,753,345 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,570 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 57,215 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 160 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.